Northwestern University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Northwestern University sits in the top decile of US sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count).
Northwestern University: 1,209 sponsored US clinical trials, 187 recruiting.
Northwestern University sponsors 1,209 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 767 completed. 114 of these trials are in Phase 3-4 (later-stage) and 295 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 11 trials.
Top-decile sponsor footprint
Northwestern University ranks in the top decile of sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
767 of 912 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,209 total, page 23 of 25
Improving Motivation for Physical Activity in Arthritis Clinical Trial
NCT00248105
Incidence of Obstructive Sleep Apnea in Pregnancy
NCT00462306
The Impact of Treating Staphylococcus Aureus Infection and Colonization on the Clinical Severity of Atopic Dermatitis
NCT00179959
Stem Cell Transplantation in Idiopathic Inflammatory Myopathy Diseases
NCT00278564
Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
NCT00234052
Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study
NCT00225017
Stress Management for Patients With Multiple Sclerosis
NCT00147446
Translating the DPP Into the Community
NCT00302042
Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor
NCT00711243
Lenalidomide in Treating Patients With Relapsed Mycosis Fungoides/Sezary Syndrome
NCT00466921
Problem-solving: A Stroke Caregiver Early Intervention
NCT01141738
Pilot Study of Denileukin Diftitox Plus High-Dose IL-2 for Patients With Metastatic Renal Cancer
NCT00278369
A Trial of Two Steroid-Free Approaches Toward Mycophenolate Mofetil-Based Monotherapy Immunosuppression
NCT00166712
Crohn's Disease Stem Cell Transplantation
NCT00271947
Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH
NCT00267670
Imatinib Mesylate and Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Pancreatic Cancer
NCT00281996
Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy
NCT00278629
Phase I/II Study of High-Dose Calcitriol Plus Temodar for Patients With Metastatic Melanoma
NCT00301067
Traumatic Ulnar Translocation of the Carpus
NCT01258166
Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
NCT00530010
Radiolabeled Glass Beads in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery
NCT00532740
SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial Function
NCT00225082
Stem Cell Injection for Peripheral Vascular Disease
NCT00278603
Improving Aspirin Use in Diabetes: A Cluster Randomized Trial
NCT00262977
Effect of Timing on Efficacy of Morphine Analgesia After 2-chloroprocaine Anesthesia
NCT00487084
Make Better Choices Study
NCT00113672
Conversion of Hyperglycemic Patients Being Treated With Intravenous Insulin Infusions to Lantus Insulin
NCT00338104
High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy
NCT00131924
Brain Imaging of Lidoderm for Chronic Back Pain
NCT01515540
Coagulation Factor Changes Associated With Postpartum Hysterectomies
NCT00456547
Partner Assistance in Learning and Performing Skin Self-Examination
NCT01013844
Hematopoietic Stem Cell Support in Patients With Refractory Sarcoidosis
NCT00282438
Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL
NCT00089284
Prevention of Weight Gain in Adult Patients With Type 2 Diabetes Treated With Pioglitazone
NCT00737347
Circadian Rhythms and Sleep in Familial DSPS and ASPS
NCT00246454
Improving Functioning in Peripheral Arterial Disease
NCT00106327
Hematopoietic Stem Cell Support in Vasculitis
NCT00278512
In Vivo Angiostatin Generation Using Tissue Plasminogen Activator and Captopril in Treating Patients With Progressive Metastatic Cancer
NCT00086723
Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer
NCT00073866
Effect of 4-Hydroxytamoxifen Gel on Breast Density, Salivary Sex Steroids, and Quality of Life in Premenopausal Women
NCT00084344
Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation
NCT00058188
Effect of Tamoxifen on Breast Density in Premenopausal Women With Breast Cancer or High Risk for Breast Cancer
NCT00086749
Serotonin 1A Agonists and Cognition in Schizophrenia
NCT00178971
Genistein in Treating Patients With Localized Prostate Cancer Who Are Planning to Undergo Radical Prostatectomy
NCT00058266
Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma
NCT00057980
Platelet Count Trends in Pre-eclamptic Parturients
NCT00787241
Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer
NCT00058006
Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study
NCT00271934
Rheumatoid Arthritis:Tolerance Induction by Mixed Chimerism
NCT00282412
The Effect of Combined Spinal-Epidural Analgesia on the Success of External Cephalic Version (ECV) for Breech Position
NCT00565383
What is open in the Northwestern University pipeline
187 recruiting of 1,209 indexed (15% open); 767 completed (63%).
Phase mix: 114 late (III/IV) vs 295 early (I/II) (early-phase heavy).
Top condition: Depression (11 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Northwestern University: open-pipeline peers nationwide
Peers matched on 1,209 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,209 trials (± recruiting share)
- Emory University · 1,208 trials · 17% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Brigham and Women's Hospital · 15% recruiting · 937 trials
- Incyte Corporation · 15% recruiting · 239 trials
- Nationwide Children's Hospital · 15% recruiting · 188 trials
- University of Michigan Rogel Cancer Center · 15% recruiting · 292 trials
Related
What to do with this Northwestern University page
1,209 registered trials is a research-attention snapshot, not an endorsement of Northwestern University or any single study.
- 187 of Northwestern University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition Northwestern University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Northwestern University pipeline card: 1,209 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.